Last reviewed · How we verify
HEC169584 capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HEC169584 capsule (HEC169584 capsule) — Sunshine Lake Pharma Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HEC169584 capsule TARGET | HEC169584 capsule | Sunshine Lake Pharma Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HEC169584 capsule CI watch — RSS
- HEC169584 capsule CI watch — Atom
- HEC169584 capsule CI watch — JSON
- HEC169584 capsule alone — RSS
Cite this brief
Drug Landscape (2026). HEC169584 capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/hec169584-capsule. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing